Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Telomerase inhibitor
DRUG CLASS:
Telomerase inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
tretinoin (6)
BIBR1532 (1)
sodium metaarsenite (1)
tertomotide (1)
THIO (0)
GX301 (0)
imetelstat (0)
suratadenoturev (0)
VAC2 (0)
bisantrene (0)
tretinoin (6)
BIBR1532 (1)
sodium metaarsenite (1)
tertomotide (1)
THIO (0)
GX301 (0)
imetelstat (0)
suratadenoturev (0)
VAC2 (0)
bisantrene (0)
›
Associations
(9)
News
Trials
VERI cancer hierarchy
Reset Filters
CCL11 overexpression
Pancreatic Ductal Adenocarcinoma
CCL11 overexpression
Pancreatic Ductal Adenocarcinoma
tertomotide
Sensitive: B - Late Trials
tertomotide
Sensitive
:
B
tertomotide
Sensitive: B - Late Trials
tertomotide
Sensitive
:
B
MYB underexpression
Adenoid Cystic Carcinoma
MYB underexpression
Adenoid Cystic Carcinoma
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
NOTCH1 mutation
Adenoid Cystic Carcinoma
NOTCH1 mutation
Adenoid Cystic Carcinoma
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
WT1 overexpression
Myelodysplastic Syndrome
WT1 overexpression
Myelodysplastic Syndrome
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
TP53 mutation
Myelodysplastic Syndrome
TP53 mutation
Myelodysplastic Syndrome
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
ASXL1 mutation
Myelodysplastic Syndrome
ASXL1 mutation
Myelodysplastic Syndrome
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
cytarabine + decitabine + tretinoin
Sensitive: C3 – Early Trials
cytarabine + decitabine + tretinoin
Sensitive
:
C3
PML-RARA fusion
Acute Promyelocytic Leukemia
PML-RARA fusion
Acute Promyelocytic Leukemia
tretinoin + arsenic trioxide
Sensitive: C3 – Early Trials
tretinoin + arsenic trioxide
Sensitive
:
C3
tretinoin + arsenic trioxide
Sensitive: C3 – Early Trials
tretinoin + arsenic trioxide
Sensitive
:
C3
AKT1 overexpression
Glioblastoma
AKT1 overexpression
Glioblastoma
sodium metaarsenite
Sensitive: D – Preclinical
sodium metaarsenite
Sensitive
:
D
sodium metaarsenite
Sensitive: D – Preclinical
sodium metaarsenite
Sensitive
:
D
TP53 mutation
Acute Myelogenous Leukemia
TP53 mutation
Acute Myelogenous Leukemia
BIBR1532
Sensitive: D – Preclinical
BIBR1532
Sensitive
:
D
BIBR1532
Sensitive: D – Preclinical
BIBR1532
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login